First Patient Enrolled in Phase 3 COMET Study Evaluating Sanofi's (SNY) NeoGAA in Treatment of Pompe Disease

Source Link:

http://www.prnewswire.com/news-releases/pivotal-phase-3-trial-of-neogaa-investigational-second-generation-therapy-for-pompe-disease-to-begin-in-the-uk-601634945.html